FINSUM + Magnifi: How to Adapt as China Pulls the Reins on Stimulus

(March 2021)

The U.S. is set to ramp up its stimulus efforts as it passes the Biden Administrations' $1.9 trillion covid relief package. China, however, is preparing to curb spending. The People’s Bank of China will begin to close the faucet as money market liquidity, government bond issuance, and private credit growth all taper. In a typical slowdown, one could expect major changes for China. However, economist Carol Liao and Pimco strategist Gene Frieda believe this could be different. The Biden stimulus package will boost demand in the U.S. and developing markets. This could be a stabilizing force for China, particularly in the commodities markets. The yuan looks more attractive as currency movements can lag credit swings. Finally, U.S. tariff relief could be promising for the country's currency.

Source: Barrons

(New York)


FINSUM + Magnifi: Chinese markets appear to be sluggish in response to lower stimulus and other factors. But there are a variety of reasons including U.S. stimulus that bearish investors are overplaying their hand when it comes to China. 



New call-to-action

Magnifi is changing the way we shop for investments, with the world’s first semantic search engine for finance that helps users discover, compare and buy investment products such as ETFs, mutual funds and stocks. As of March 2021, 250,000+ users with $475+ Billion in Assets Under Influence, has used Magnifi over 1,200,000 times. Try it for yourself today.

 

This blog is sponsored by Magnifi. The information and data are as of the publish date unless otherwise noted and subject to change. This material is provided for informational purposes only and should not be construed as individualized investment advice or an offer or solicitation to buy or sell securities tailored to your needs. This information covers investment and market activity, industry or sector trends, or other broad-based economic or market conditions and should not be construed as investment research or advice. Investors are urged to consult with their financial advisors before buying or selling any securities. Although certain information has been obtained from sources believed to be reliable, we do not guarantee its accuracy, completeness or fairness. Past performance is no guarantee of future results. This content may not be reproduced or distributed to any person in whole or in part without the prior written consent of Magnifi. [As a technology company, Magnifi provides access to tools and will be compensated for providing such access. Magnifi does not provide brokerage or custody services.]

 

New call-to-action

Magnifi in Action: Discover "Low Cost Healthcare Funds"

Click on any fund in the chart below to dig deeper.